Compare Old Dominion Freight Line Inc (ODFL) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Old Dominion Freight Line Inc vs Pfizer Inc — how do they compare? Old Dominion Freight Line Inc trades at $183.23 (market cap $37.68B), while Pfizer Inc trades at $27.83 (market cap $159.59B). The key difference: Pfizer Inc is far larger — about 4.2× Old Dominion Freight Line Inc's market cap, and Pfizer Inc pays the higher dividend (6.14%). Which is the better fit depends on your goals — on Pluang, investors hold Old Dominion Freight Line Inc for 76 Days and Pfizer Inc for 158 Days on average.
| ODFL | PFE | |
|---|---|---|
Market Cap | $37.68B | $159.59B |
Volume | 1,550,104 | 30,937,010 |
Sector | Industrials | Health |
52-Week High | $248.73 | $29.02 |
52-Week Low | $126.29 | $23.67 |
Typical Hold Time | 76 Days | 158 Days |
Enterprise Value | $37.42B | $211.09B |
Dividend Yield | 0.64% | 6.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Old Dominion Freight Line (ODFL) trades at $175.61, down 1.35% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.68 exceeding the $1.54 estimate. Revenue for 2025 was $5.50B, with a net income margin of 19.44%. A 4.9% general rate increase effective October 5, 2026, aims to support service investments amid cost pressures.
ODFL presents a mixed outlook; analyst consensus is a Buy with a $230.93 price target, implying significant upside, but technical indicators suggest near-term pressure. Risks include freight demand volatility and high valuation multiples. The stock's investment case hinges on execution of rate increases and sustained operational efficiency in a competitive trucking sector.
Pfizer (PFE) trades at $27.82, up 1.22% with a bullish technical signal from moving averages. The company shows stable revenue around $62-63B with consistent earnings beats in recent quarters. Analysts maintain a $29.40 consensus target with 40% buy ratings. Recent news highlights Pfizer's focus on obesity and oncology pipelines as key growth drivers.
Pfizer offers value with defensive cash flows and dividend stability, though patent cliffs and margin compression present challenges. The stock's current valuation appears reasonable relative to sector peers, with upside potential if pipeline developments succeed. Key risks include competitive pressures and regulatory hurdles for new drug approvals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Old Dominion Freight Line Inc
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
